SPY315.99+1.61 0.51%
DIA259.60+2.36 0.92%
IXIC10,551.51+3.76 0.04%

Verrica Pharmaceuticals Q3 EPS $(0.24) Up From $(0.27) YoY

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.24) per share. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year.

Benzinga · -

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.24) per share. This is a 11.11 percent increase over losses of $(0.27) per share from the same period last year.